Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BFC vs BuCy Conditioning for Adult B-ALL HSCT
NCT05379569Phase 4Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- May 2022
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of fludarabine in Acute B-cell lymphoblastic leukemia (B-ALL), sponsored by Shanghai General Hospital. Started May 2022; status: recruiting.
02
Drugs
fludarabine
03
Conditions
Acute B-cell lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT05379569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05379569.